Hey Steve - I disagree - I don't see it as pumping to state facts and you have furnished us with many, along with your opinions based on those. Pumping? No. What has always bothered me is the 'dumping' in conflict with the reality of BIEL. Yes, there are management issues that need addressing, but the company will not be selling Whelans, and the FDA is not assessing approvals of Whelans - BIEL involves ActiPatch, ALLAY, RecoveryRx and many others in the product line.
I posted to you the following message on January 17 based on what I understood to be the facts at that moment in time. A lot has happened since then including a doubling in SP. If BIEL and its BOD can get help on the management horsepower side and the FDA approvals I think it deserves, along with other companies in the PEMF device space, my opinion is this puppy will fly. Is that pumping? Or, closer to reality than simply pounding something for the sake of pounding it.
January 17 to Steve43
Hey Steve - when you mention all the countries that have issued OTC regulatory approval for BIEL's product line, like Health Canada and in the UK, please don't forget the FDA here at home. The FDA has approved BIEL's 'RecoveryRx' product as a healing accelerator device for post-op opthalmic surgery patients, when prescribed, with remarkable results. Imagine that!
But, now, I choose to completely ignore the almost OCD naysayers and stick solely with the facts of BIEL products.
Fact - ActiPatch really works well - I know first-hand because I used it on a serious injury and my doctor could not believe the results;
Fact - it is financially affordable;
Fact - it is not a drug no chemicals rampant with side-effects;
Fact - there has never been one, not one, negative side-effect, imagine a BIEL TV slot - "sorry no negative side-effects";
Fact - we, along with BIEL management, must be patient, success takes time;
Fact - BIEL's management could have done several things differently, but we don't know anything about the decisions they faced and why, so we should have no comment now about the past;
Fact - the FDA didn't get it right first time either, it's new, and the FDA is now re-assessing all PEMF devices;
Fact - many very, very bright, articulate scientists have put their knowledge and wisdom forward in support of BIEL and other firms; and
Fact - I have said all this before, as have many posters here, and not one naysayer has refuted one word of the facts.
AI
